The industry must now address critical challenges, including pricing negotiations, payer coverage limitations, supply constraints and the preservation of muscle mass during weight loss, with solutions emerging through novel mechanisms targeting amylin, cannabinoid receptors and activin pathways. 1 Sales Projections Far Outpace Other Drugs on Clarivates 2026 Watch List An FDA decision on orforglipron is expected by March 2026, with Clarivate projecting retatrutide will be ready for launch in 2028
Its more difficult to maintain a healthy weight, which is why those people have to do everything to keep their metabolism up. This can include weight training, regular exercise, and eating whole foods
Repeat weekly
Introducing Peptide Labz GHK-Cu Copper Peptide Body Wash, designed to elevate your daily skincare routine
A New Era for Diabetes and Weight Management in India Imagine a once-weekly injection that helps your body release insulin only when blood sugar is high, reduces constant food cravings, and in large clinical trials lowers the risk of major cardiovascular events including heart attack and stroke by 20% in people who are overweight
(1996) shows that when GH and IGF-1 are combined, they can significantly counteract weight loss and promote weight gain, particularly in the case of burned rats
